Brief: CSL Expands Relationship With Haemonetics Corporation
BRIEF-CSL Expands Relationship With Haemonetics Corporation Oct 8 (Reuters) - CSL Limited CSL.AX:
EXPANDS RELATIONSHIP WITH HAEMONETICS CORPORATION
TO COMPLETE HAEMONETICS PLATFORM ROLLOUT IN U.S. PLASMA CENTRES BY END 2027
ENTERS AGREEMENT WITH TERUMO BCT TO SUPPORT PLATFORM TRANSITION
TRANSITION TO HAEMONETICS PLATFORM TO INCREASE PLASMA COLLECTION NETWORK EFFICIENCY
Further company coverage: CSL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CSL
See all newsCiti says CSL's CEO pick brings key strengths
Australia's CSL names GSK executive Waterhouse as next CEO (updated)
Brief: CSL Limited Appoints Deborah Waterhouse As CEO And Managing Director
Australia's CSL appoints Deborah Waterhouse as CEO
Early US flu season, current strain may signal risk for younger people; doctors urge shots